Stock TOVX THERIVA BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Theriva Biologics, Inc.

Equities

TOVX

US87164U4094

Biotechnology & Medical Research

Market Closed - Nyse
Other stock markets
 16:10:00 2024-05-20 EDT 		5-day change 1st Jan Change
0.37 USD -0.19% Intraday chart for Theriva Biologics, Inc. -1.10% -13.97%
05-07 Theriva Biologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-23 Theriva Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8.519 7.657 35.94 6.878 7.33 6.357 - -
Enterprise Value (EV) 1 8.519 7.657 35.94 6.878 7.33 6.357 6.357 6.357
P/E ratio -0.52 x -0.58 x -1.43 x -0.35 x -0.38 x -0.46 x -0.49 x -0.55 x
Yield - - - - - - - -
Capitalization / Revenue - - - - - - - -
EV / Revenue - - - - - - - -
EV / EBITDA - - - - - - - -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 1,681 1,999 13,204 15,124 17,043 17,148 - -
Reference price 2 5.069 3.830 2.722 0.4548 0.4301 0.3707 0.3707 0.3707
Announcement Date 2/20/20 3/4/21 3/16/22 3/30/23 3/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - - - - -
EBITDA - - - - - - - -
EBIT 1 -15.66 -10.16 -14.27 -21.58 -21.43 -28.57 -34.29 -37.13
Operating Margin - - - - - - - -
Earnings before Tax (EBT) 1 - -10.12 -14.27 -21.11 -19.99 -28.57 -34.29 -37.13
Net income 1 -16.08 -12.56 -23.19 -19.68 -18.35 -28.57 -34.29 -37.13
Net margin - - - - - - - -
EPS 2 -9.800 -6.600 -1.900 -1.310 -1.140 -0.8100 -0.7600 -0.6700
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/20/20 3/4/21 3/16/22 3/30/23 3/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - - - - - - - - - - -
EBITDA - - - - - - - - - - - - -
EBIT 1 -5.265 - -4.985 -5.014 -7.33 -5.178 -5.82 -4.218 -6.217 -5.392 -6.857 -7.429 -7.715
Operating Margin - - - - - - - - - - - - -
Earnings before Tax (EBT) 1 -5.263 - -4.968 -4.853 -7.016 -4.808 -5.443 -3.83 -5.909 -5.165 -6.857 -7.429 -7.715
Net income 1 -5.263 - -4.968 -4.853 -5.591 -4.478 -5.084 -3.303 -5.485 -5.165 -6.857 -7.429 -7.715
Net margin - - - - - - - - - - - - -
EPS 2 -0.4000 - -0.3100 -0.3300 -0.3600 -0.3000 -0.3400 -0.1900 -0.3300 -0.3000 -0.1900 -0.2100 -0.2200
Dividend per Share - - - - - - - - - - - - -
Announcement Date 3/16/22 5/16/22 8/11/22 11/10/22 3/30/23 5/11/23 8/8/23 11/13/23 3/25/24 5/7/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 2/20/20 3/4/21 3/16/22 3/30/23 3/25/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.3707 USD
Average target price
2 USD
Spread / Average Target
+439.52%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
THERIVA BIOLOGICS, INC. Stock Theriva Biologics, Inc.
-13.97% 6.36M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.58% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.41% 106B
ARGENX SE Stock argenx SE
-2.59% 21.96B
BIONTECH SE Stock BioNTech SE
-12.38% 21.87B
GENMAB A/S Stock Genmab A/S
-5.29% 19.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-3.35% 18.08B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.57% 17.71B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.51% 14.32B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.67% 12.42B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. TOVX Stock
  4. Financials Theriva Biologics, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW